Disclosed in certain embodiments is a pharmaceutical composition
comprising a sugar; a Krebs cycle intermediate, precursor of a Krebs
cycle intermediate, salt thereof, or combination thereof; and a component
selected from the group consisting of an unsaturated lipid,
phenylethylamine, a soluble calcium compound, or a combination thereof.